Thorp Clay insider trades
Thorp Clay has filed 14 Form 4s with the SEC that we hold, for Clearside Biomedical, Inc. (CLSD) (Director), PHAS (Director) and VIGL (Director). Across all of them we count 8 purchases worth $3.9M and 1 sale worth $145.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 265,000 shares of VIGL worth $3.7M, dated 2022-01-11. The first filing on our record is dated 2021-08-18 and the latest 2025-02-24.
Clearside Biomedical, Inc. (CLSD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-02-10 | S, sale reported on Form 4 | 32,873 | $145.6K | 2022-12-19 |
| 2022-12-21 | P, purchase reported on Form 4 | 14,000 | $14.3K | 2022-12-21 |
| 2023-09-25 | P, purchase reported on Form 4 | 10,000 | $8.6K | 2023-09-25 |
| 2025-02-24 | P, purchase reported on Form 4 | 15,000 | $13.8K | 2025-02-24 |
PHAS
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-18 | P, purchase reported on Form 4 | 10,000 | $30.0K | 2021-08-18 |
VIGL
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-11 | P, purchase reported on Form 4 | 265,000 | $3.7M | 2022-01-11 |
| 2022-03-28 | P, purchase reported on Form 4 | 3,000 | $21.6K | 2022-03-28 |
| 2022-05-16 | P, purchase reported on Form 4 | 21,802 | $60.2K | 2022-05-17 |
| 2022-05-17 | P, purchase reported on Form 4 | 14,893 | $44.2K | 2022-05-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1592380) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms